These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 29946108)

  • 1. Sex differences in neural mechanisms mediating reward and addiction.
    Becker JB; Chartoff E
    Neuropsychopharmacology; 2019 Jan; 44(1):166-183. PubMed ID: 29946108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addiction and brain reward and antireward pathways.
    Gardner EL
    Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent updates on incubation of drug craving: a mini-review.
    Li X; Caprioli D; Marchant NJ
    Addict Biol; 2015 Sep; 20(5):872-6. PubMed ID: 25440081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.
    Chartoff EH; Mavrikaki M
    Front Neurosci; 2015; 9():466. PubMed ID: 26733781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in addiction.
    Becker JB
    Dialogues Clin Neurosci; 2016 Dec; 18(4):395-402. PubMed ID: 28179811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiology of addiction: insight from neurochemical imaging.
    Urban NB; Martinez D
    Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobiology of abstinence-induced reward-seeking in males and females.
    Alonso-Caraballo Y; Guha SK; Chartoff EH
    Pharmacol Biochem Behav; 2021 Jan; 200():173088. PubMed ID: 33333134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and Differences in Neurobiology.
    Chen M; Sun Y; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():45-58. PubMed ID: 29098667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuropeptide-centric view of psychostimulant addiction.
    Boutrel B
    Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
    Brabant C; Alleva L; Quertemont E; Tirelli E
    Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments on the neurobiological and pharmaco-genetic mechanisms underlying internet and videogame addiction.
    Weinstein A; Lejoyeux M
    Am J Addict; 2015 Mar; 24(2):117-125. PubMed ID: 25864599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system.
    Sagheddu C; Melis M
    CNS Neurol Disord Drug Targets; 2015; 14(4):502-17. PubMed ID: 25714966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of neurotransmitters in the brain circuitry: Mesolimbic pathway and addiction.
    Ebrahimi MN; Banazadeh M; Alitaneh Z; Jaafari Suha A; Esmaeili A; Hasannejad-Asl B; Siahposht-Khachaki A; Hassanshahi A; Bagheri-Mohammadi S
    Physiol Behav; 2024 Oct; 284():114639. PubMed ID: 39004195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approach to the neurobiological mechanisms of addiction.
    Fürst Z; Riba P; Al-Khrasani M
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):189-205. PubMed ID: 24380960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focusing on the Opioid System for Addiction Biomarker Discovery.
    Belzeaux R; Lalanne L; Kieffer BL; Lutz PE
    Trends Mol Med; 2018 Feb; 24(2):206-220. PubMed ID: 29396147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous opioids and addiction to alcohol and other drugs of abuse.
    Gianoulakis C
    Curr Top Med Chem; 2004; 4(1):39-50. PubMed ID: 14754375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.